A. Ferrajoli

Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLL

D. Marin, T. Kadia, E. Jabbour, 2017, Bone Marrow Transplantation.

Lenalidomide: an emerging option in chronic lymphocytic leukemia

J. Reuben, M. Keating, S. O'brien, 2009 .

Phase 1 and Extension Study of Clofarabine plus Cyclophosphamide in Patients with Relapsed / Refractory Acute Lymphoblastic Leukemia ( ALL )

J. Cortes, T. Kadia, F. Ravandi, 2014 .

P365: INCORPORATION OF NELARABINE (NEL), PEGYLATED ASPARAGINASE (PEG) AND VENETOCLAX (VEN) IN THE FRONTLINE THERAPY OF ADULT PATIENTS WITH T-ACUTE LYMPHOBLASTIC LEUKEMIA/T-LYMPHOBLASTIC LYMPHOMA (T-ALL/LBL)

T. Kadia, F. Ravandi, E. Jabbour, 2022, HemaSphere.

P371: HYPER-CVAD WITH SEQUENTIAL BLINATUMOMAB, WITH OR WITHOUT INOTUZUMAB OZOGAMICIN, IN ADULTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

T. Kadia, F. Ravandi, E. Jabbour, 2022, HemaSphere.

P651: VENETOCLAX-BASED TREATMENT OF PATIENTS WITH RICHTER SYNDROME: OUTCOMES FROM A MULTICENTER RETROSPECTIVE STUDY

Yu Wang, T. Call, W. Ding, 2022, HemaSphere.

S149: LONG TERM OUTCOMES OF IFCG REGIMEN FOR FIRSTLINE TREATMENT OF PATIENTS WITH CLL WITH MUTATED IGHV AND WITHOUT DEL(17P)/TP53 MUTATION

M. Konopleva, Z. Estrov, T. Kadia, 2022, HemaSphere.